In this regard, the results of Junqueira's study suggested that increasing the expression level of the AIM2 gene in COVID-19 patients, as one of the important molecules, might contribute to exacerbation of the condition of hospitalized patients (Junqueira et al., 2021[15]). This evidence concerns the gene AIM2 and COVID-19.